These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 10777704)
1. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Hara K; Okada T; Tobe K; Yasuda K; Mori Y; Kadowaki H; Hagura R; Akanuma Y; Kimura S; Ito C; Kadowaki T Biochem Biophys Res Commun; 2000 Apr; 271(1):212-6. PubMed ID: 10777704 [TBL] [Abstract][Full Text] [Related]
2. Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects. Kawasaki I; Tahara H; Emoto M; Shoji T; Shioji A; Okuno Y; Inaba M; Nishizawa Y Osaka City Med J; 2002 Jun; 48(1):23-8. PubMed ID: 12375694 [TBL] [Abstract][Full Text] [Related]
3. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus]. Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686 [TBL] [Abstract][Full Text] [Related]
4. Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects. Niskanen L; Lindi V; Erkkilä A; Sivenius K; Luoma J; Ylä-Herttuala S; Laakso M; Uusitupa MI Metabolism; 2003 Feb; 52(2):213-7. PubMed ID: 12601635 [TBL] [Abstract][Full Text] [Related]
5. Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus. Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scalissi N; Speranza AC; Hirata MH Diabetes Obes Metab; 2005 Sep; 7(5):605-11. PubMed ID: 16050954 [TBL] [Abstract][Full Text] [Related]
6. The Pro12Ala polymorphism of the PPAR gamma 2 gene regulates weight from birth to adulthood. Pihlajamäki J; Vanhala M; Vanhala P; Laakso M Obes Res; 2004 Feb; 12(2):187-90. PubMed ID: 14981210 [TBL] [Abstract][Full Text] [Related]
7. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus. Ringel J; Engeli S; Distler A; Sharma AM Biochem Biophys Res Commun; 1999 Jan; 254(2):450-3. PubMed ID: 9918859 [TBL] [Abstract][Full Text] [Related]
8. The PPARgamma2 polymorphism pro12Ala is associated with better insulin sensitivity in the offspring of type 2 diabetic patients. Jacob S; Stumvoll M; Becker R; Koch M; Nielsen M; Löblein K; Maerker E; Volk A; Renn W; Balletshofer B; Machicao F; Rett K; Häring HU Horm Metab Res; 2000 Oct; 32(10):413-6. PubMed ID: 11069206 [TBL] [Abstract][Full Text] [Related]
9. Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes. Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K Arch Med Res; 2006 Aug; 37(6):736-43. PubMed ID: 16824933 [TBL] [Abstract][Full Text] [Related]
10. Sibling-based association study of the PPARgamma2 Pro12Ala polymorphism and metabolic variables in Chinese and Japanese hypertension families: a SAPPHIRe study. Stanford Asian-Pacific Program in Hypertension and Insulin Resistance. Chuang LM; Hsiung CA; Chen YD; Ho LT; Sheu WH; Pei D; Nakatsuka CH; Cox D; Pratt RE; Lei HH; Tai TY J Mol Med (Berl); 2001 Nov; 79(11):656-64. PubMed ID: 11715069 [TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor gamma 2 Pro12Ala gene variant is strongly associated with larger body mass in the Taiwanese. Lei HH; Chen MH; Yang WS; Chiu MC; Chen MC; Tai TY; Chuang LM Metabolism; 2000 Oct; 49(10):1267-70. PubMed ID: 11079814 [TBL] [Abstract][Full Text] [Related]
12. The role of PPARgamma as a thrifty gene both in mice and humans. Hara K; Kubota N; Tobe K; Terauchi Y; Miki H; Komeda K; Tamemoto H; Yamauchi T; Hagura R; Ito C; Akanuma Y; Kadowaki T Br J Nutr; 2000 Dec; 84 Suppl 2():S235-9. PubMed ID: 11242476 [TBL] [Abstract][Full Text] [Related]
13. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus. Ek J; Andersen G; Urhammer SA; Gaede PH; Drivsholm T; Borch-Johnsen K; Hansen T; Pedersen O Diabetologia; 2001 Dec; 44(12):2220-6. PubMed ID: 11793024 [TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-gamma2-Pro12Ala and endothelial nitric oxide synthase-4a/bgene polymorphisms are associated with essential hypertension. Rodríguez-Esparragón FJ; Rodríguez-Pérez JC; Macías-Reyes A; Alamo-Santana F J Hypertens; 2003 Sep; 21(9):1649-55. PubMed ID: 12923396 [TBL] [Abstract][Full Text] [Related]
15. [Association of Pro12Ala mutation in peroxisome proliferator-activated receptor gamma 2 with obesity and diabetes in Chinese population]. Wang C; Zhai F; Chi Y; Wang G Wei Sheng Yan Jiu; 2004 May; 33(3):317-20. PubMed ID: 15211802 [TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with type 2 diabetes. Lee BC; Lee HJ; Chung JH Neurosci Lett; 2006 Dec; 410(2):141-5. PubMed ID: 17084528 [TBL] [Abstract][Full Text] [Related]
17. The role of PPARgamma in high-fat diet-induced obesity and insulin resistance. Kadowaki T; Hara K; Kubota N; Tobe K; Terauchi Y; Yamauchi T; Eto K; Kadowaki H; Noda M; Hagura R; Akanuma Y J Diabetes Complications; 2002; 16(1):41-5. PubMed ID: 11872365 [TBL] [Abstract][Full Text] [Related]
18. Effects of Pro12Ala polymorphism of peroxisome proliferator-activated receptor gamma2 gene on rosiglitazone response in type 2 diabetes. Kang ES; Park SY; Kim HJ; Kim CS; Ahn CW; Cha BS; Lim SK; Nam CM; Lee HC Clin Pharmacol Ther; 2005 Aug; 78(2):202-8. PubMed ID: 16084854 [TBL] [Abstract][Full Text] [Related]
19. Association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor gamma2 gene with small dense low-density lipoprotein in the general population. Hamada T; Kotani K; Tsuzaki K; Sano Y; Murata T; Tabata M; Sato S; Sakane N Metabolism; 2007 Oct; 56(10):1345-9. PubMed ID: 17884443 [TBL] [Abstract][Full Text] [Related]
20. The silent PPARgamma exon 6 CAC(His) --> CAT(His) polymorphism does not affect the plasma leptin levels in a collective of first degree relatives of type 2 diabetes patients from South West Germany. Koch M; Rett K; Maerker E; Volk A; Haist K; Deninger M; Rettig A; Renn W; Häring HU Exp Clin Endocrinol Diabetes; 2000; 108(5):341-6. PubMed ID: 10989952 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]